Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 176 institutions that hold shares in the stock, with a total of 132 Million shares, which have been reported (via 13F filing form) to have a value of $358 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Tpg Gp A, LLC
Fort Worth, TX |
Aug 14, 2024 Q2 2024 |
18,716,306
shares
|
$54.5 Million
1.08% of portfolio
|
Q4 2021
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$47.9 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
8,195,666
shares
|
$23.8 Million
0.0% of portfolio
|
Q2 2024
Reduced 0.14%
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
7,668,124
shares
|
$22.3 Million
0.0% of portfolio
|
Q2 2024
Reduced 16.51%
|
|
Capital World Investors
Los Angeles, CA |
Aug 13, 2024 Q2 2024 |
6,896,552
shares
|
$20.1 Million
0.0% of portfolio
|
Q2 2024
New holding
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2024 Q2 2024 |
5,790,542
shares
|
$16.9 Million
0.0% of portfolio
|
Q2 2024
Added 38.61%
|
|
Primecap Management CO
Pasadena, CA |
Aug 09, 2024 Q2 2024 |
5,670,226
shares
|
$16.5 Million
0.01% of portfolio
|
Q2 2024
Added 4.07%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
4,358,989
shares
|
$12.7 Million
0.1% of portfolio
|
Q2 2024
Added 65.49%
|
|
Jpmorgan Chase & CO
New York, NY |
Aug 12, 2024 Q2 2024 |
4,124,854
shares
|
$12 Million
0.0% of portfolio
|
Q2 2024
Reduced 20.4%
|
|
Boxer Capital, LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
3,850,000
shares
|
$11.2 Million
0.5% of portfolio
|
Q1 2024
New holding
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
2,960,673
shares
|
$8.62 Million
0.02% of portfolio
|
Q2 2024
Added 54.9%
|
|
Wildcat Capital Management, LLC
|
Aug 14, 2024 Q2 2024 |
2,920,787
shares
|
$8.5 Million
1.7% of portfolio
|
Q2 2024
Added 52.06%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 15, 2024 Q2 2024 |
2,867,750
shares
|
$8.35 Million
0.39% of portfolio
|
Q1 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
2,820,034
shares
|
$8.21 Million
0.0% of portfolio
|
Q2 2024
Added 18.92%
|
|
Perceptive Advisors LLC
New York, NY |
Aug 16, 2024 Q2 2024 |
2,725,000
shares
|
$7.93 Million
0.18% of portfolio
|
Q2 2024
New holding
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 09, 2024 Q2 2024 |
2,550,640
shares
|
$7.42 Million
0.0% of portfolio
|
Q2 2024
Added 24.81%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
2,446,503
shares
|
$7.12 Million
0.0% of portfolio
|
Q2 2024
Reduced 21.42%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2024 Q2 2024 |
2,242,500
shares
|
$6.53 Million
0.01% of portfolio
|
Q2 2024
Added 68.47%
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
2,200,000
shares
|
$6.4 Million
0.38% of portfolio
|
Q2 2024
Added 62.96%
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
2,156,962
shares
|
$6.28 Million
0.0% of portfolio
|
Q1 2024
Added 33.82%
|
|
Vida Ventures Advisors, LLC
|
Jul 10, 2024 Q2 2024 |
1,798,163
shares
|
$5.23 Million
7.29% of portfolio
|
Q3 2020
New holding
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
1,747,955
shares
|
$5.09 Million
0.01% of portfolio
|
Q2 2024
Added 340.4%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
1,530,047
shares
|
$4.45 Million
0.0% of portfolio
|
Q2 2024
Added 18.18%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2024 Q2 2024 |
1,178,401
shares
|
$3.43 Million
0.0% of portfolio
|
Q2 2024
Added 37.27%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
1,038,105
shares
|
$3.02 Million
0.0% of portfolio
|
Q2 2024
Added 6.9%
|